Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03912025 · ClinicalTrials.gov registry record
The Relationship Between Having a Positive Mindset and Exercise Capacity in Patients With Congenital Heart Disease
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 90
- Enrollment target
NCT03912025: Completed study, sponsored by Boston Children's Hospital.
NCT03912025 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03912025 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
A cross sectional study utilizing congenital heart disease patients presenting for clinically indicated cardiopulmonary exercise test. Baseline questionnaires (see below) will be administered prior to the exercise test. Exercise test data and clinical data will be recorded. Questionnaire data will be compared to clinical data in and between disease severity groups. Disease severity will be determined based on hemodynamic (not anatomic) classification according to an algorithm adapted from the European Society of Cardiology.
Primary Outcome
A series of 8 questions that ask about future hopes, created and validated by a branch of the National Institutes of Health (www.healthmeasures.net). The final score is represented by the T-score, a standardized score with a mean of 50 and a standard deviation (SD) of 10. A higher PROMIS T-score represents more of the concept being measured. For positively-worded concepts like Meaning and Purpose, a T-score of 60 is one SD better than average. By comparison, a Meaning and Purpose T-score of 40 i
Interventions
- OTHER Relationship between positive mindset and exercise capacity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2021-04-25 |
What the finished NCT03912025 record still lists
NCT03912025 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Relationship between positive mindset and exercise capacity is the first listed.
NCT03912025 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03912025 about?
NCT03912025 is a clinical study titled "The Relationship Between Having a Positive Mindset and Exercise Capacity in Patients With Congenital Heart Disease". A cross sectional study utilizing congenital heart disease patients presenting for clinically indicated cardiopulmonary exercise test. Baseline questionnaires (see below) will be administered prior to the exercise test. Exercise test data and clinical data will be recorded. Questionnaire data will b...
What is the current status of trial NCT03912025?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2020-01-30. Estimated completion is 2021-04-25.
What interventions are being tested in trial NCT03912025?
The interventions under investigation include: Relationship between positive mindset and exercise capacity (OTHER).
Who is sponsoring clinical trial NCT03912025?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI